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Introduction {#sec001}
============

Yeast *Saccharomyces cerevisiae* was considered to be a harmless microorganism; however, occasional reports of uncommon infections that were attributed to *S*. *cerevisiae* were revealed since 1980 \[[@pone.0135174.ref001]--[@pone.0135174.ref006]\]. The clinical isolates of *S*. *cerevisiae* were first genetically characterized as pathogens in 1994 \[[@pone.0135174.ref007]\]. Some clinical isolates showed pathogenic potential by proliferating and causing death in DBA/2 mice, but non-clinical yeast strains did not \[[@pone.0135174.ref008], [@pone.0135174.ref009]\]. Therefore, *S*. *cerevisiae* has been regarded as one of emerging opportunistic yeast infections \[[@pone.0135174.ref010]--[@pone.0135174.ref014]\]. Several virulence factors have been addressed between clinical and laboratory strains of *S*. *cerevisiae*, such as thermotolerance and pseudohyphal formation \[[@pone.0135174.ref007]\]; however, the correlation between these traits and the composition of the cell wall proteome requires further elucidation.

Yeast cell walls are essential for the survival of fungal cells. Two primary components of the inner part of *S*. *cerevisiae* cell wall, β-glucan and chitin, are served as scaffold and recognized by specialized innate immune receptors \[[@pone.0135174.ref015], [@pone.0135174.ref016]\]. It has been demonstrated that the predominant yeast cell wall molecule, β-glucan, is a potent immunostimulatory molecule \[[@pone.0135174.ref017]\]. In addition, mannoproteins, mainly glycosylphosphatidylinositol (GPI)-modified CWPs and alkali-sensitive linkage (ASL)-CWPs located at the outer part of cell wall, have been demonstrated to be involved in adhesion to host cells, virulence, fungal morphogenesis, cell wall biogenesis, and biofilm formation \[[@pone.0135174.ref018]--[@pone.0135174.ref023]\]. The association between cell surface polysaccharides and immune recognition of fungi also suggested that the changes in yeast cell surface properties may be responsible for increased virulence \[[@pone.0135174.ref015], [@pone.0135174.ref016], [@pone.0135174.ref024], [@pone.0135174.ref025]\]. Mutants with changes in the composition of cell walls may be more virulent because of the altered cell surface that leads to misrecognition by the innate immune system and stimulation of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 \[[@pone.0135174.ref026]\]. It has been shown that overproduction of proinflammatory cytokines, such as TNF-α stimulated by hypervirulent yeasts, is associated with septic shock in mice \[[@pone.0135174.ref026], [@pone.0135174.ref027]\].In addition, a similar overall cell wall structure exists in related fungi, such as human pathogens *Candida albicans* and *Candida glabrata* \[[@pone.0135174.ref028], [@pone.0135174.ref029]\]. Therefore, deciphering the cell surface architecture of clinical isolates of *S*. *cerevisiae* may highlight new determinants of fungal virulence.

Mass spectrometry-based proteomics has provided a powerful tool for systematic elucidation of yeast *S*. *cerevisiae* proteome. SILAC (stable isotope labeling by amino acids in cell culture) labeling of yeast was applied to generate one-to-one pairs of peptide signals which facilitates a highly reliable measurement of relative and absolute protein amounts \[[@pone.0135174.ref030]--[@pone.0135174.ref032]\]. Here we used the auxotrophic lab strain for stable isotope incorporation, and further compared its cell wall protein profile quantitatively to the clinical isolates. We found that Scw10p, Pst1p, and Pir family proteins, such as Pir1p, Hsp150p/Pir2p, and Cis3/Pir4p, were expressed significantly higher in clinical isolates than in S288c lab strain. In particular, high levels of Hsp150p enhanced cell wall integrity and the ability of adherence to polystyrene surface. Strains overexpressed *HSP150* were more potent to elicit proinflammatory cytokine TNF-α from macrophages, suggesting that alteration of cell wall composition and architecture causes yeast hypervirulent.

Materials and Methods {#sec002}
=====================

Strains and Media {#sec003}
-----------------

Strains were grown in YPD (1% (w/v) yeast extract, 2% (w/v) bactopeptone, and 2% (w/v) glucose) media and harvested at A~600~ = 0.8--1.2. YYC1-3 were isolated and obtained from National Taiwan University Hospital, Taipei, Taiwan. YJM309 (YYC38) was the gift from John McCusker of Duke University Medical Center, North Carolina \[[@pone.0135174.ref007]\]. Σ1278b (YYC304) was obtained from Fang-Jen Lee at National Taiwan University, Taipei, Taiwan. YYC377 (MAT a/α *his3Δ1/ his3Δ1 leu2Δ0/ leu2Δ0 LYS2/lys2Δ0 MET15/met15Δ0 ura3Δ0/ ura3Δ0*) is the diploid strain in S288c background generated by mating BY4741 and BY4742, the parental strains of Yeast Deletion Project obtained from Wen-Hsiung Li at Academia Sinica, Taipei, Taiwan. YYC370 (MAT a/α *ADE2/ade2Δ*::*hisG HIS3/his3Δ200 leu2Δ0/leu2Δ0 lys2Δ0/lys2Δ0 MET15/met15Δ0 TRP1/trp1Δ63 URA3/ ura3Δ0*) is also the diploid strain in S288c background generated by mating BY4704 and BY4739 obtained from Wen-Hsiung Li at Academia Sinica, Taipei, Taiwan. The *hsp150* deletion strain in BY4741 background (MAT a *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hsp150Δ*::*KanMX4*) was obtained from Wen-Hsiung Li at Academia Sinica, Taipei, Taiwan. For Calcofluor white (CFW) or Congo Red (CR) sensitivity assay, overnight cultures were diluted and spotted to YPD plates with 50 μg/mL CFW or 100μg/mL CR and incubated at 30°C for 3 days.

YYC173 is the segregant of YYC1. *HSP150-173* and *HSP150-288* alleles were amplified by PCR from YYC173 and S288c strains respectively with a Myc tag inserted into the end of the ORFs. The PCR products were digested with restriction enzymes *Bam*HI and *Sal*I and then subcloned into the vector pRS415-*GAL1*, which is the gift from Tien-Hsien Chang at Academia Sinica, Taipei, Taiwan. The constructs were transformed into *hsp150Δ* deletion strain, and the expression of *HSP150* alleles were driven by *GAL1* promoter by growing in SC-galactose media (0.67% (w/v) yeast nitrogen base and 2% (w/v) galactose). For CFW or CR sensitivity assay, overnight cultures were diluted and spotted to SC-galactose plates with 500 μg/mL CFW or 150 μg/mL CR and incubated at 30°C for 3 days.

Cell Hydrophobicity Assay {#sec004}
-------------------------

Determination of cell surface hydrophobicity using MATH (microbial adhesion to hydrocarbons) test was performed as described before \[[@pone.0135174.ref033]\], with some modifications. Yeast cells were grown in YPD media for overnight, washed in distilled water, and resuspended in 10 mM potassium phosphate buffer (pH 4) so that the basic OD~600~ of the suspension (A~0~) was 1.0. 80 μL *o*-xylene was added to a 800 μL suspension, vortexed at top speed for 1 min, and allowed to settle for 10 min. The OD~600~ of the aqueous phase (A~t~) was measured. The hydrophobicity was calculated by the percentage of cells adhered to *o*-xylene: Adhesion to xylene (%) = (1- A~t~ /A~0~) x 100. The strains were considered more hydrophobic if the percentage of adhesion is higher. Statistical significance was measured by Student's *t* test.

Adhesion Assay {#sec005}
--------------

Adherence of *S*. *cerevisiae* to polystyrene surface was performed as describe before \[[@pone.0135174.ref034], [@pone.0135174.ref035]\]. Strains were harvested and washed with distilled water twice, and then resuspended to 1.0 OD~600~ in YPD media with 0.1% glucose. 100 μL of cell suspension was transferred into wells of a 96-well polystyrene plate (SPL Life Sciences, Korea) and incubated at 30°C for 1 hr. Cell suspension was then removed and cells adhere to polystyrene were stained with 100 μL 1% (w/v) crystal violet for 15 min \[[@pone.0135174.ref035]\]. The wells were washed repeatedly with distilled water, and 100 μL of 33.3% acetic acid were added to release bound crystal violet. The absorbance was measure at 590 nm. Statistical significance was measured by Student's *t* test.

SILAC Labeling {#sec006}
--------------

SILAC labeling was performed as described before \[[@pone.0135174.ref030]\] with modifications. Clinical isolates YYC1-3, YYC38, and YYC 370 were grown in "light" SD-glucose media (0.67% (w/v) yeast nitrogen base, 2% (w/v) glucose, and amino acid supplements 50 mg/L adenine, 20 mg/L L-histidine, 100 mg/L L-leucine, 20 mg/L methionine, 20 mg/L L-tryptophan, and 20 mg/L uracil) with additional 30 mg/L normal L-lysine (Sigma). YYC370 were grown in "heavy" SD-glucose media, which is the SD-glucose media but with 30 mg/L L-lysine (4,4,5,5-D4) (Cambridge Isotope Laboratories, Inc.) instead of normal L-lysine. Either light or heavy SILAC-labeled yeast cells were grown for more than 20 generations and harvested at A~600~ = 0.8--1.2. Equal amounts of each light and heavy cells (as determined by A~600~ measurement) were then mixed 1:1, harvested and washed for cell wall preparation. The mixture of equal amounts of light and heavy YYC370 was served as controls of our quantification later.

Cell Wall Isolation {#sec007}
-------------------

Cell walls were isolated as described \[[@pone.0135174.ref036], [@pone.0135174.ref037]\]. Briefly, mid-log phase of cells were harvested and resuspended in 10 mM Tris-HCl, pH 7.5. Cells were fully broken with 0.55-mm glass beads (Thomas Scientific, USA) in the presence of protease inhibitor (Roche). Cell wall debris was obtained by centrifugation at 4,500xg for 15 min. To remove noncovalently linked proteins and intracellular contaminants, isolated cell walls were washed extensively with 1 M NaCl and then resuspended in extraction buffer (2% SDS, 100 mM Na-EDTA, 40mM β-mercaptoethanol, and 50 mM Tris-HCl, pH 7.8) and boiled for 5 min at 100°C. The extraction procedures were repeated, and SDS-extracted walls were washed three times with water and stored at -20°C until use.

LC-MS/MS Analysis and SILAC Quantitation {#sec008}
----------------------------------------

Peptides for LC-MS/MS analysis were obtained from the proteolytic digestion directly from isolated cell wall fractions. 5 biological replicates of proteomics analyses were performed. The SDS-extracted cell walls were reduced by dithiothreitol (10 mM) at 55°C for 30 min followed by alkylation by iodoacetamide (50 mM) at room temperature for 30 min in the dark. Cell wall fractions were digested overnight by sequencing grade trypsin. After enzymatic reaction, peptides in the supernatants were collected and dried under vacuum.

Nano-LC-MS/MS experiments were performed on a LTQ-FT mass spectrometer (Thermo Scientific, Inc., Waltham, MA) with a nano-electrospray ion source (New Objective, Inc., Woburn, MA) in positive ion mode. The liquid chromatographic separation was using Agilent 1100 Series binary high-performance liquid chromatography system (Agilent Technologies, Palo Alto, CA) with Famos autosampler (LC Packings, San Francisco, CA). Peptide samples were injected onto a self-packed pre-column (150 μm I.D. x 20 mm, 5μm, 200 Å) followed by a self-packed reversed phase C18 nano-column (75 μm I.D. x 300 mm, 5μm, 100 Å) for chromatographic separation. A linear gradient of 5 to 40% mobile phase B (0.1% formic acid in 80% acetonitrile) was applied for 100 min at a flow rate of 300 nL/min. The positive ion mode was used in MS analysis with electrospray voltage of 2 kV and capillary temperature at 200°C. A MS scan cycle was initiated with a survey MS spectrum (m/z 300--2000) performed on the FT-ICR mass spectrometer with resolution of 100,000 at 400 Da. Ten most abundant ions detected in this scan were subjected to a MS/MS experiment performed in the LTQ mass spectrometer. Ion accumulation (Auto Gain Control target number) and maximal ion accumulation time for survey MS and MS/MS were set at 1 x 10^6^ ions, 1000 ms and 5 x 10^4^ ions, 200 ms respectively. Ions were fragmented by use of CID (collision induced dissociation) with the following parameters: the normalized collision energy to 35%, the activation Q to 0.3, and the activation time to 30 ms.

For data analysis, all MS/MS spectra were converted to mzXML format from experiment RAW files by MM File Conversion Tools ([http://www.massmatrix.net](http://www.massmatrix.net/) \[[@pone.0135174.ref038]\]), and then analyzed by MassMatrix \[[@pone.0135174.ref039]\] for MS/MS ion search as well as SILAC quantitation. Searches were performed with a precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.6 Da. Trypsin was assigned as the enzyme for data analysis with the miss cleavage number three. The oxidation of methionine, carbamidomethylation of cysteine, phosphorylation of serine/threonine/tyrosine, and acetylation of lysine were assigned as variable modifications in search parameters. Relative quantification results were directly outputted from MassMatrix and compared to two other methods, the automatic quantification by MaxQuant and manual quantification. The statistical significance was determined by two-way ANOVA.

Macrophage Stimulation and TNF-α Measurement {#sec009}
--------------------------------------------

Murine RAW 264.7 macrophage cell line was a gift from Betty Wu-Hsieh at National Taiwan University, Taipei, Taiwan, originally obtained from the American Type Culture Collection, Rockville, Md., and cultured in DMEM-10 (DMEM (Biological Industries, Israel) with 10% heat-inactivated FCS (GE Healthcare), 1x of Hyclone non-essential amino acids (GE Healthcare), 100 unit/mL penicillin, 0.1 mg/mL streptomycin, and 250 ng/mL amphotericin B) \[[@pone.0135174.ref040], [@pone.0135174.ref041]\]. Yeast cells were added at a yeast to macrophage ratio of 60 and allowed to bind and phagocytosed for 30 min at 37°C. Macrophages were washed twice with PBS to remove unbound yeast and incubated in 0.5 mL of DMEM-10 for 6 hr. Murine TNF-α levels in culture supernatants were measured by ELISA according to the manufacturer's instructions (R & D system). Infections were done in duplicate or triplicate and ELISA measurements were taken in duplicate or triplicate. Statistical significance was measured using Student's *t* test.

Results and Discussion {#sec010}
======================

Clinical Isolates of *S*. *cerevisiae* Were More Hydrophobic and Capable of Adhering to Plastic Surfaces {#sec011}
--------------------------------------------------------------------------------------------------------

Yeast cellular surface hydrophobicity has been shown as a potentially important pathogenic factor involved in adherence and biofilm formation \[[@pone.0135174.ref042]\]. First we investigated the cell surface characteristics between the laboratory strain and the clinical isolates of *S*. *cerevisiae* by the MATH test, in which the partition of cells in *o*-xylene represents a quantitative measurement of hydrophobicity \[[@pone.0135174.ref033], [@pone.0135174.ref043]\]. While hydrophobic strain YYC304 in Σ1278b background and clinical isolate YYC38 showed that about 43--45% of cells adhered to *o*-xylene, the clinical isolates YYC1-3 all showed 13--18% of adherence, about increased up to 1.5 to 2 folds comparing to lab strain S288c ([Fig 1A](#pone.0135174.g001){ref-type="fig"}). It indicated that all four clinical strains tested showed significantly hydrophobic cell surfaces, while the S288c laboratory strain was relatively hydrophilic.

![The *S*. *cerevisiae* clinical isolates showed hydrophobic cellular surface and resistant to cell wall-perturbing agents.\
Strains S288c and YYC304 were served as negative and positive controls respectively. The clinical isolates YYCs 1--3 and 38 were subjected to cell hydrophobicity assay (A), adhesion assay (B), and sensitivity assay with 50 μg/mL CFW or 100 μg/mL CR (C) as described. Serial 5-fold dilutions of each strain were spotted on solid YPD media or in the presence of CFW or CR. The plates were incubated at 30°C for 3 days. 3 biological replicates were performed. Asterisks indicate statistically significant differences from S288c (*p* \< 0.05).](pone.0135174.g001){#pone.0135174.g001}

On the other hand, cell surface property also affects the adherence to polystyrene plates. Attached cells were stained with crystal violet and absorbance at 590 nm were measured proportional to cell numbers. We found that the mount of cells adhesive to polystyrene surface was dramatically increased up to 4.2--14 folds in all four clinical strains tested comparing to the S288c laboratory strain ([Fig 1B](#pone.0135174.g001){ref-type="fig"}). To further investigate the difference of cell wall structure and integrity between the lab strains and clinical isolates, we examined strain sensitivity to cell wall-perturbing agents CR and CFW, which interfere with construction and biosynthesis of the main architecture of cell wall. Wild-type S288c strain showed hypersensitive to high concentration of 100 μg/ml of CR or 50 μg/ml of CFW, while three of the clinical isolates except YYC2 were much more resistant to these two agents ([Fig 1C](#pone.0135174.g001){ref-type="fig"}). All these results indicated that the cell wall characteristics of the clinical isolates of *S*. *cerevisiae* recognizably vary from S288c.

Comprehensive Mass-Spectrometry-Based Proteome Quantification of CWPs {#sec012}
---------------------------------------------------------------------

To investigate the variation of fungal cell wall proteomics between the lab strain and the clinical isolates, we established analyses of *S*. *cerevisiae* CWPs by mass spectrometry. Cells growing into mid-log phase were collected, and SDS-treated cell walls were subjected to trypsin digestion to obtain peptide fragments which were further separated and sequenced by LC-MS/MS. Totally 25 CWPs were successfully identified from log-phase cells, including 15 GPI-modified proteins, 7 ASL-CWPs, and 3 other CWPs: Bgl2p, Ssa1p, and Tdh3p ([Table 1](#pone.0135174.t001){ref-type="table"}), which are comparative to previous results \[[@pone.0135174.ref037]\]. However, since CWPs are potentially highly glycosylated, we cannot rule out that proteins would be missed if the trypsinized fragments fall out of the range detectable by LC-MS/MS in our analysis. Orthologs in *C*. *albicans* or *C*. *glabrata* for each protein were found based on *Candida* Genome Database (<http://www.candidagenome.org/>) except Cwp1p, Mkc7p, and Pry3p. Bgl2p is characterized as a beta-1,3-glucanase which introduces intrachain linkages and is involved in cell wall structure maintenance \[[@pone.0135174.ref044], [@pone.0135174.ref045]\]. Ssa1p is a chaperone protein belonging to HSP70 family. Although most of the Ssa proteins were found in the cytosol, it has been reported that Ssa1p was also detected in the cell wall \[[@pone.0135174.ref046]\]. Tdh3p is one of the isozymes of glyceraldehyde-3-phosphate dehydrogenases (GAPDHs). It has been interestingly detected in both the cytoplasm and cell wall \[[@pone.0135174.ref047]\].

10.1371/journal.pone.0135174.t001

###### There were totally 25 CWPs identified by LC-MS/MS analysis.

![](pone.0135174.t001){#pone.0135174.t001g}

  Standard Name   Function                                   Homolog in *Candida* species             \# of peptides Quantified/Detected
  --------------- ------------------------------------------ ---------------------------------------- ------------------------------------
  **GPI-CWP**                                                                                         
  Ccw12p          Cell wall mannoprotein                     Pga62p (Ca)                              0 / 1
  Ccw14p/Ssr1p    Cell wall glycoprotein                     Ssr1p (Ca, Cg)                           4 / 4
  Crh1p           Chitin transglycosylase                    Crh11p (Ca); Crh1p (Cg)                  9 / 12
  Crh2p/Utr2p     Chitin transglycosylase                    Utr2p (Cg)                               2 / 3
  Cwp1p           Cell wall mannoprotein                     \-                                       7 / 7
  Cwp2p           Cell wall mannoprotein                     Tir1p; Tir2p (Cg)                        0 / 1
  Ecm33p          Unknown                                    Ecm33p; Pst1 (Cg)                        5 / 5
  Exg2p           Exo-1,3-beta-glucanase                     CAGL0M08756g (Cg)                        0 / 1
  Gas1p           β-1,3-glucanosyltransferase                Gas1p, Gas2p (Cg); Phr1p, Phr2p (Ca)     7 / 11
  Gas3p           β-1,3-glucanosyltransferase                Gas4p (Cg)                               4 / 9
  Gas5p           β-1,3-glucanosyltransferase                Gas5p (Cg); Pga4p (Ca)                   3 / 6
  Mkc7p           Aspartyl protease                          \-                                       0 / 1
  Plb2p           Phospholipase B                            Plb2p (Cg); Plb3p (Ca)                   0 / 1
  Pry3p           Cell wall-associated protein               \-                                       0 / 1
  Pst1p           Cell wall protein                          Pst1p; Ecm33p (Cg)                       1 / 3
  **ASL-CWP**                                                                                         
  Pir1p           O-glycosylated protein                     Pir1p; Pir2p; Pir3p (Cg)                 2 / 3
  Pir2p/Hsp150p   O-mannosylated heat shock protein          Pir1p; Pir2p; Pir3p; Pir4p; Pir5p (Cg)   2 / 3
  Pir3p           O-glycosylated protein                     Pir1p; Pir2p; Pir3p; Pir4p (Cg)          0 / 1
  Pir4p/Cis3p     Mannose-containing glycoprotein            Pir1p; Pir2p; Pir3p; Pir4p (Cg)          6 / 7
  Scw4p           Glucanase                                  Scw4p; MP65 (Cg); MP65 (Ca)              3 / 10
  Scw10p          Glucanase                                  Scw4p; MP65 (Cg); MP65 (Ca)              4 / 6
  Tos1p           Cell wall protein                          CAGL0M05599g (Cg); Tos1p (Ca)            3 / 3
  **Others**                                                                                          
  Bgl2p           Endo-beta-1,3-glucanase                    CAGL0G00220g (Cg); Bgl2p (Ca)            0 / 1
  Tdh3p           Glyceraldehyde-3-phosphate dehydrogenase   CAGL0J00451g, Tdh3p (Cg); Tdh3p (Ca);    0 / 12
  Ssa1p           ATPase                                     Ssa1p; Ssa3p (Cg); Ssa2p; Hsp70p (Ca)    0 / 11

The possible function and the homologs in *C*. *albicans* or *C*. *glabrata* for each characterized protein were listed. The peptide numbers used for quantification vs. protein identification were listed in the last column. EF-1α, Pdc1p, and Pma1p were internal controls to normalize the quantification results. Ca, *Candida albicans*; Cg, *Candida glabrata*.

To further quantitate the covalently linked CWPs between the clinical and lab strains, SILAC labeling followed by LC-MS/MS was used as an easy and accurate approach for CWP relative quantitation. The experimental scheme was illustrated in [Fig 2](#pone.0135174.g002){ref-type="fig"}, and the details were described in Materials and Methods. The S288c lab strain YYC370 was labeled with stable isotope incorporated amino acid L-lysine (4,4,5,5-D4) supplemented in growth media. In contrast, each of the clinical isolates YYC1, 2, 3, and 38 was cultured in the growth media containing regular amino acids. Equal cell numbers of S288c (heavy) and a clinical strain (light) were mixed together for CWPs isolation followed by trypsin digestion. Tryptic peptides were subjected to LC-MS/MS analyses, and peptide sequences and their abundances were further determined by MassMatrix. 15 of 25 CWPs were qualified for quantitation and the ratios of each CWP levels in particular clinical strain were calculated relative to those in S288c as shown in [Fig 3](#pone.0135174.g003){ref-type="fig"}. Similar results were obtained by MaxQuant automatic quantification or manual quantification (Supporting Information). The numbers and sequences of peptides detected and subjected to further quantification were listed in [Table 1](#pone.0135174.t001){ref-type="table"} and Supporting Information. The mixture of equal amounts of light and heavy YYC370 were also subjected to our quantitation, and the ratios for each protein levels were ranged from 1.02 to 1.33, indicating the accuracy of our quantitative analysis.

![Strategy used to identify and quantify *S*. *cerevisiae* cell wall proteome.\
SILAC labeling followed by Nano-LC-MS/MS was used for relative quantitation.](pone.0135174.g002){#pone.0135174.g002}

![Scw10p, Pst1p and Hsp150p were expressed at significantly higher levels in the clinical isolates than in S288c.\
The protein levels in clinical isolates (YYC1-3 and 38) relative to S288c strain YYC370 were presented after normalization to the internal controls EF1-α, Pdc1p, and Pma1p. (A) GPI-CWPs and (B) ASL-CWPs. 5 biological replicates were performed and the averages were shown here.](pone.0135174.g003){#pone.0135174.g003}

Within 15 CWPs analyzed, cell wall proteins Cis3p, Crh1p, Hsp150p, and Scw10p were all expressed significantly higher in all 4 clinical isolates than in S288c lab strain, and higher levels of Ecm33p, Pir1p, Pst1p, and Scw4p were observed in 3 out of 4 clinical isolates ([Fig 3](#pone.0135174.g003){ref-type="fig"}). Scw10p, Pst1p, and Hsp150p were top 3 proteins expressed at least 2 folds higher in clinical isolates than in S288c lab strain. In contrast, the expression levels of Ccw14p were about the same in all the clinical isolates relative to lab strain. We examined the mRNA levels of *HSP150* in S288c and clinical isolates and found that *HSP150* transcripts in clinical isolates were surprisingly slightly reduced (data not shown). We suspected that the increased Hsp150p protein abundance was more likely due to post-transcriptional regulation. Scw10p, one of ASL-CWPs with potential glucanase activity, has been suggested to play a role in conjugation during mating \[[@pone.0135174.ref048]\]. However, how the Scw10p contributed to cell surface property of clinical isolates is still uncertain. Notably, we observed Pst1p, a GPI-modified protein homologous to Ecm33p, covalently incorporated in cell wall fraction of exponential-phase cells. Interestingly, our quantification results showed that Pst1p expressed at significantly 3 to 8-fold higher levels in clinical isolates than in S288c lab strain ([Fig 3A](#pone.0135174.g003){ref-type="fig"}), while Ecm33p expression only increased modestly about 2 folds. The function of Pst1p is still unknown but it was reported to be upregulated by cell wall damage or by cell integrity pathway \[[@pone.0135174.ref049], [@pone.0135174.ref050]\]. Nevertheless, the *C*. *albicans* ortholog of Pst1p is not found, but Ecm33p is required for its virulence \[[@pone.0135174.ref051]\]. We therefore speculate that Pst1p in *S*. *cerevisiae* might be correlated to strain pathogenicity. The role of Pst1p up-regulation in clinical isolates of *S*. *cerevisiae* still remains to be further investigated. However, there is no direct evidence showing that Scw10p or Pst1p is related to fungal pathogenicity to our knowledge.

Pir proteins, including Pir1p, Pir2/Hsp150p, Pir3p, and Pir4/Cis3p in *S*. *cerevisiae*, apparently attach to cell wall via 1,3-glucan through alkali-sensitive linkages. An N-terminal signal peptide, a Kex2 site, multiple PIR repeat-containing regions, and a carboxyl-terminal region with four cysteine residues were highly conserved in Pir family. Hsp150p/Pir2p is one of the members in Pir family which are regulated by cell integrity pathway and required for cell wall stability \[[@pone.0135174.ref052], [@pone.0135174.ref053]\]. Among 5 Pir proteins found in *S*. *cerevisiae*, despite the fact that Pir5p is still a putative protein of unknown function, and Pir3p was unable to be quantified in our analyses, Pir1p, Hsp150p/Pir2p, and Cis3p/Pir4p levels were all considerably increased in clinical isolates analyzed ([Fig 3B](#pone.0135174.g003){ref-type="fig"}). The protein sequence of Hsp150p from clinical isolate YYC173 (Hsp150-173) was aligned with 5 Pir family proteins from lab strain S288c in [Fig 4A](#pone.0135174.g004){ref-type="fig"}. Hsp150-173 is one PIR repeat shorter and 98% identical to Hsp150p from S288c lab strain. On the other hand, Hsp150p showed 54--81% identity to other Pir proteins. Amazingly, the C-terminal regions with 4-cysteine domains in particular are highly conserved among all Pir proteins. The sequence data indicated that the Hsp150p protein abundance but not structural difference may play critical roles in the phenotypes we observed in clinical isolates. By comparing Pir2/Hsp150p orthologs across species, *C*. *albicans* ortholog CaPir1p and *C*. *glabrata* ortholog CgPir2p were identified by an *in silico* search of *Candida* Genome Database and aligned in [Fig 4B](#pone.0135174.g004){ref-type="fig"}. It showed that Hsp150p/Pir2p orthologs among *S*. *cerevisiae* and *Candida* species are also highly conserved in C-terminal regions including 4 cysteine residues. Surprisingly, the sequence identity of Hsp150p/Pir2p between *S*. *cerevisiae* and *C*. *glabrata* are also as high as 80%. The C-terminal repeated regions are serine/threonine rich, and are thought to be greatly O-mannosylated. In addition, in our quantitative results, other Pir family proteins such as Pir1p and Cis3p were also expressed at moderate higher levels in the clinical isolates, suggesting that the abundance of Pir proteins might play a certain role exceptionally in clinical isolates.

![Protein sequence alignment of Pir family.\
The protein sequence of *HSP150-173*, the *HSP150* allele of clinical isolate YYC173, was deduced from its DNA sequencing results. (A) Pir family protein sequences of Pir1p, Hsp150p, Pir3p, Cis3p, and Pir5p from lab strain S288c, extracted from *Saccharomyces* Genome Database, together with Hsp150-173 were aligned. (B) Hsp150p/Pir2p protein orthologous sequences of *Candida albicans (C*. *a*.*)* and *Candida glabrata (C*. *g*.*)*, extracted from *Candida* Genome Database, as well as sequence of *S*. *cerevisiae* (S. c.) were aligned. All the sequences were aligned by Clustal Omega (<http://www.clustal.org/omega/>).](pone.0135174.g004){#pone.0135174.g004}

Kex2p is a calcium-dependent serine protease, and Kex2 sites were conserved in all Pir proteins of *S*. *cerevisiae*. It has been reported that CaKex2p is required for hyphal growth and virulence in mice \[[@pone.0135174.ref054]\], suggesting that *S*. *cerevisiae* Pir proteins, the Kex2p substrates, might also play roles in fungal virulence. CaPir1p with PIR repeats is essential in *C*. *albicans* \[[@pone.0135174.ref055]\]. CaPir1p showed 9 PIR repeats, whereas we observed ScPir1p, ScPir2/Hsp150p, ScPir3p, and ScPir4p with 8, 10, 7, and 1 repeat(s) respectively. Whether the number of repeats play a role in *S*. *cerevisiae* is still unclear yet.

High Levels of Hsp150p Enhance Cell Wall Integrity and the Ability of Adherence to Polystyrene Surface {#sec013}
------------------------------------------------------------------------------------------------------

In order to further investigate whether higher levels of Hsp150p play roles in cell wall property, we tested the cell hydrophobicity and plastic adhesion ability in *HSP150* overexpressed S288c lab strain. We found that cell hydrophobicity was not significantly changed in *hsp150*-deleted strain or *HSP150* overexpressed strains ([Fig 5A](#pone.0135174.g005){ref-type="fig"}), indicating that Hsp150p expression perhaps showed modest effect on cell surface hydrophobicity. On the other hand, plastic adhesion increased up to 3 to 4 folds in *HSP150* overexpressed strains ([Fig 5B](#pone.0135174.g005){ref-type="fig"}), suggesting that Hsp150p may be important for the ability of adherence to polystyrene surface. We also investigated the property of cell wall structure and integrity in *HSP150* overexpressed cells with the treatment of higher concentration of CR (150 μg/ml) or CFW (500 μg/ml). Although *hsp150Δ* was still more sensitive than WT at low concentrations of CR (100 μg/ml) or CFW (50 μg/ml), our data revealed that at higher concentrations of CR or CFW, strains with highly expressed Hsp150p were much more resistant to cell wall-perturbing agents, while the WT and *hsp150Δ* were very sensitive ([Fig 5C](#pone.0135174.g005){ref-type="fig"}). Deletion of *HSP150* in YYC1 background also increased the sensitivity to CR or CFW. It suggested that Hsp150p played a crucial role in cell wall integrity. All our data suggested that up-regulation of cell wall protein Hsp150p is essential for maintenance of cell wall characteristics in yeasts.

![Overexpression of Hsp150p increased cell wall integrity and the ability of adherence to polystyrene surface.\
Strains S288c and YYC304 were served as negative and positive controls respectively. The *hsp150Δ* strain containing the control vector, the allele *HSP150-288* of S288c strain, or the allele *HSP150-173* of YYC173, were subjected to cell hydrophobicity assay (A), adhesion assay (B), and sensitivity assay with CFW or CR with indicated concentrations (C) as described. Serial 2-fold dilutions of each strain were spotted on solid SC-galactose media or in the presence of CFW or CR. The plates were incubated at 30°C for 3 days. 3 biological replicates were performed. Asterisks indicate statistically significant differences (*p* \< 0.05).](pone.0135174.g005){#pone.0135174.g005}

Overexpression of Hsp150p Enhances the Virulence in Yeast {#sec014}
---------------------------------------------------------

Yeast cell wall is the outermost structure which potentially leads to misrecognition and overstimulation of proinflammatory cytokines by host innate immune system. We further tested whether the changes of cell wall protein composition may be one of the virulence traits in the clinical isolates we observed. The enhancement of TNF-α production stimulated by lab strains and clinical isolates was performed in murine macrophage cell line RAW264.7. We found that comparison to the WT lab strain, clinical isolates YYC1 and YYC38 stimulated at least 3-fold more TNF-α ([Fig 6A](#pone.0135174.g006){ref-type="fig"}). Overexpression of Hsp150p in lab strains also showed the enhancement of TNF-α production; however, the induction levels showed no difference between *HSP150-288* and *HSP150-173* alleles ([Fig 6B](#pone.0135174.g006){ref-type="fig"}). Our results indicated that the hypervirulence of clinical isolates may be, at least partially, due to the proinflammatory response overstimulated by overexpression of certain cell wall proteins, for example Hsp150p. Moreover, we speculated that Pir2/Hsp150p might be the one in Pir family that is the most functionally equivalent to CaPir1p in fungal pathogenicity.

![Overexpression of Hsp150p elicits greater proinflammatory cytokine TNF-α induction in macrophage cell line.\
Murine macrophage cell line RAW264.7 was exposed to clinical isolates (A), and YYC173, *hsp150Δ* strain containing the control vector, overexpressed the allele *HSP150-288*, or allele *HSP150-173* (B) as indicated. NC, macrophage treated without any yeast cells. 2 or 3 biological replicates were performed. Asterisks indicate statistically significant differences from S288c (A) or *hsp150Δ* (B) (*p* \< 0.05).](pone.0135174.g006){#pone.0135174.g006}

Fungal virulence was considered multi-factorial. Several key virulence factors have been addressed in *C*. *albicans*. Secreted aspartic proteases (Saps) have been recognized as a virulence-associated trait \[[@pone.0135174.ref056], [@pone.0135174.ref057]\]. The infectious ability of *C*. *albicans* is closely related to its ability of biofilm formation \[[@pone.0135174.ref058], [@pone.0135174.ref059]\]. In *Aspergillus fumigatus*, a protein phosphatase 2A SitA was identified as a possible modulator for adhesion, cell wall integrity, biofilm formation, and virulence \[[@pone.0135174.ref060]\]. Several virulence factors have been addressed in *S*. *cerevisiae* such as thermotolerance and pseudohyphal formation \[[@pone.0135174.ref061]\]. Although the emergence of virulent isolates is still puzzling, here we reported that the change in cell wall protein composition in *S*. *cerevisiae* is related to its hydrophobicity, adhesion, cell wall integrity, and virulence.

Conclusions {#sec015}
===========

The yeast cell wall is a dynamic structure with a layer of glucan and chitin molecules as scaffold for the outer layer of glycoproteins, and we reported here the first study of cell wall quantitative proteomics in clinical isolates of *S*. *cerevisiae* by SILAC labeling followed by LC-MS/MS analysis. Our results indicated that clinical isolates of *S*. *cerevisiae* showed distinct characteristics of cell wall, such as higher hydrophobicity, higher ability of adherence, and higher levels of certain CWPs, including Hsp150p, indicating the discrepancy of the cell wall structure or composition between clinical isolates and lab strain S288c. In addition, we also showed that overexpression of Hsp150p enhances the virulence of yeast. Our findings in this study will lead to a better understanding of CWPs as well as the pathogenicity of clinical isolates of *S*. *cerevisiae*.

Supporting Information {#sec016}
======================

###### An illustration of the mass shift and quantification for peptide VGQSLSIVSNDELSK with Lys-D0 and Lys-D4 labeling.

\(A\) MS spectrum shows a 2 m/z difference for doubly charged peptides; and (B) MS/MS spectrum shows no different for b11, b12, and b13 ions but with a 4 m/z shift for y11 and y12 ions. (C) Manual quantification of peaks for peptides with both Lys-D0 and Lys-D4 labeling from LC chromatogram.
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Click here for additional data file.

###### List of peptides from cell wall proteins for SILAC quantification.
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Click here for additional data file.

###### List of peptides from cytoplasmic proteins as the internal control for SILAC quantification.
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Click here for additional data file.

###### The averaged relative quantitative levels of cell wall proteins analyzed by MassMatrix (MM) and MaxQuant (MQ).
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Click here for additional data file.
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